FDA continues co-sponsorship of MedCon conference with AFDO/RAPS Healthcare Products Collaborative
The US Food and Drug Administration (FDA) will continue its longstanding co-sponsorship of the MedCon conference. With a focus on fostering open discussions of the most pressing issues facing the medical device industry, the AFDO/RAPS Healthcare Products Collaborative recently announced that their new partnership will carry on Xavier Heath’s 12-year legacy of delivering the MedCon conference.The MedCon 2022 Conference will be held virtually 4 – 6 May 2022. The event will bring together medical device regulators and industry experts from around the world for content-rich conference sessions that include uncommon collaboration, deep dialogue and networking as close as your computer.
“The annual MedCon conference helps fulfill the Department of Health and Human Services' and FDA's important mission to protect public health,” says Gina Brackett, director, Compliance Branch at FDA ORA Office of Medical Device and Radiological Health. “MedCon has historically provided outreach and engagement with our colleagues in the medical products industry to discuss trends, innovations, and challenges in an educational setting. We are pleased that this new partnership between AFDO and RAPS intends to continue that focus. We feel it is important to be key facilitator of the discussion.”
FDA has made education of the device manufacturing community a high priority to help ensure the quality of FDA-regulated medical products.
MedCon 2022 registration is now open. For more information and to view the virtual program details, visit www.healthcareproducts.org/MedCon. Information about the Collaborative and announcements for future events can be found at www.healthcareproducts.org.